{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:55:05Z","timestamp":1767149705753,"version":"build-2238731810"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ygyno.2011.12.441","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T02:18:46Z","timestamp":1324520326000},"page":"145-150","source":"Crossref","is-referenced-by-count":3,"title":["RETRACTED: Minimally-aggressive gestational trophoblastic neoplasms"],"prefix":"10.1016","volume":"125","author":[{"given":"Laurence A.","family":"Cole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.12.441_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2009.09.028","article-title":"hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases","volume":"116","author":"Cole","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2010.01.030","article-title":"Letter to the editor with comments on article by Cole and Muller entitled hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases","volume":"116","author":"Kohorn","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2010.01.016","article-title":"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases","volume":"116","author":"Seckl","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0020","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.placenta.2007.01.011","article-title":"Hyperglycosylated hCG","volume":"28","author":"Cole","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/mawe.200300715","article-title":"Identification of the anthelix motif in the TGF-\u00df superfamily by molecular 3D-rapid prototyping","volume":"34","author":"Laub","year":"2003","journal-title":"Materialwiss Werkstofftech"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1242\/dev.104.2.263","article-title":"Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action","volume":"104","author":"Lehnert","year":"1988","journal-title":"Development"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/369455a0","article-title":"Crystal structure of hCG","volume":"369","author":"Lapthorn","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0040","doi-asserted-by":"crossref","unstructured":"Cole LA, Butler SA., in press. Hyperglycosylated hCG, hCG\u00df and Hyperglycosylated hCG\u00df: Interchangeable Cancer Promoters. Molec Cell Endocrinol 2011.","DOI":"10.1016\/j.mce.2011.10.029"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0045","first-page":"1553","article-title":"The increase in bladder carcinoma cell population induced by the free beta subunit of hCG is a result of an anti-apoptosis effect and not cell proliferation","volume":"82","author":"Butler","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0050","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1210\/jc.2004-2458","article-title":"Transfection of antisense chorionic gonadotropin \u00df gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis","volume":"90","author":"Hamade","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0055","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/j.1460-2075.1987.tb02449.x","article-title":"Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor","volume":"6","author":"Murphy","year":"1987","journal-title":"EMBO J"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0060","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.ASN.0000060574.38107.3B","article-title":"Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases","volume":"14","author":"Boffa","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/1541-7786.MCR-05-0140","article-title":"Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells","volume":"4","author":"Kwak","year":"2006","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1541-7786.MCR-07-0208","article-title":"Transforming growth factor-beta1 promotes matrix metalloproteinases-9-mediated oral cancer invasion through snail expression","volume":"6","author":"Sun","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2005.12.046","article-title":"Gestational trophoblastic diseases: 3. Human chorionic gonadotropin Free \u00df-subunit a reliable marker of placental site trophoblastic tumors","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-3-56","article-title":"Human trophoblast function during the implantation process","volume":"3","author":"Staun-Ram","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ygyno.2005.12.047","article-title":"Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2005.12.045","article-title":"Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0095","first-page":"919","article-title":"Hyperglycosylated hCG (hCG-H) in gestational implantation, and in choriocarcinoma and testicular germ cell malignancy tumorigenesis","volume":"51","author":"Cole","year":"2006","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0100","doi-asserted-by":"crossref","unstructured":"Cole LA. Chapter 13: Biological functions of hyperglycosylated hCG In: Human chorionic gonadotropin (hCG). Cole LA (Ed), Elsevier, Burlington MA, pp 145\u2013152.","DOI":"10.1016\/B978-0-12-384907-6.00002-5"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0105","unstructured":"Wikipedia, Chemotherapy, http:\/\/en.wikipedia.org\/wiki\/Chemotherapy."},{"key":"10.1016\/j.ygyno.2011.12.441_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/svms.2003.36617","article-title":"Principles of chemotherapy","volume":"18","author":"McKnight","year":"2003","journal-title":"Clin Tech Small Anim Pract"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0115","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jpedsurg.2010.02.045","article-title":"Management of unresectable solid papillary cysic tumors of the pancreas. A case report and literature review","volume":"45","author":"Soloni","year":"2010","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0120","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jpedsurg.2009.07.046","article-title":"Telomerase biology in neuroblastoma: Telomere binding proteins and alternative strnghening of telomeres","volume":"44","author":"Onitaki","year":"2009","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0125","first-page":"2623","article-title":"A case of recurrent breast cancer with extensive liver metastases successfully treated with endocrine therapy","volume":"36","author":"Kiyoto","year":"2009","journal-title":"Jpn J Cancer Chemother"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0130","first-page":"643","article-title":"Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors","volume":"53","author":"Harvey","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0135","unstructured":"Cole LA. Chapter 32: hCG, free \u00df-subunit and \u00df-core fragment as markers of malignancies. In: Human chorionic gonadotropin (hCG). Cole LA (Ed), Elsevier, Burlington MA, 2010, pp 343\u2013348."},{"key":"10.1016\/j.ygyno.2011.12.441_bb0140","first-page":"361","article-title":"Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma","volume":"93","author":"Li","year":"1956","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0145","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1210\/jcem-65-4-811","article-title":"The O-linked oligosaccharides are strikingly different on pregnancy and choriocarcinoma hCG","volume":"65","author":"Cole","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0150","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1210\/endo-113-3-1176","article-title":"Detection of the free \u00df subunit of human chorionic gonadotropin in cultures of normal and malignant trophoblast cells, pregnancy sera, and sera of patients with choriocarcinoma","volume":"113","author":"Cole","year":"1983","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0155","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/1097-0142(19920401)69:7<1818::AID-CNCR2820690726>3.0.CO;2-7","article-title":"Flow cytometry method for the analysis of membrane-associated human chorionic gonadotropin, its subunits, and fragments on human cancer cells","volume":"69","author":"Acevedo","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0160","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/1097-0142(19951015)76:8<1299::AID-CNCR2820760802>3.0.CO;2-L","article-title":"Have we found the \u201cdefinitive cancer biomarker?\u201d The diagnostic and therapeutic implications of human chorionic gonadotropin-beta statement as a key to malignancy","volume":"76","author":"Regelson","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0165","series-title":"Human chorionic gonadotropin (hCG)","first-page":"153","article-title":"Biological function of the free \u00df-subunit: expression and treatment target in cancer","author":"Butler","year":"2010"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0170","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.mce.2006.02.019","article-title":"Ectopic hCG\u00df expression by epithelial cancer: malignant behaviour metastasis and inhibition of tumor cell apoptosis","volume":"260","author":"Iles","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0175","first-page":"4666","article-title":"Ectopic human chorionic gonadotropin \u00df secretion by epithelial tumors and human chorionic gonadotropin \u00df-induced apoptosisin Karposi's sarcoma, is there a connection?","volume":"9","author":"Butler","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0180","first-page":"S243","article-title":"Human chorionic gonadotropin induces apoptosis in breast cancer","volume":"100","author":"Carter","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0185","first-page":"516","article-title":"Malignant transformation of nontrophoblastic cells in association with the expression of chorionic gonadotropin \u00df genes normally transcribed in trophoblast cells","volume":"57","author":"Bellet","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0167-4781(89)90128-0","article-title":"Chorionic gonadotropin synthesis by human tumor cell lines: examination of subunit accumulation steady-state levels of mRNA and gene structure","volume":"1007","author":"Cosgrove","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/bjc.1996.56","article-title":"The effects of \u00df-human chorionic gonadotropin on the in vitro growth of bladder cancer cell lines","volume":"73","author":"Gillott","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0200","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.mce.2006.02.018","article-title":"Designing a new generation of anti-hCG vaccines for cancer therapy","volume":"260","author":"Delves","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0205","first-page":"156","article-title":"Monoclonal antibodies to two epitopes of \u00df-human chorionic gonadotropin for the treatment of cancer","volume":"5","author":"Iversen","year":"2003","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0210","first-page":"2044","article-title":"Active specific immunotherapy with \u00df-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer. Antibody response is associated with improved survival","volume":"8","author":"Moulton","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0215","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1158\/1078-0432.CCR-11-0891","article-title":"Phase I study using a novel antigen-presenting cell-targeted vaccine with toll-like receptor stimulation to induce immunity to self-antigens in cancer patients","volume":"17","author":"Morse","year":"2011","journal-title":"Clin Chem Cancer Res"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0220","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1158\/1078-0432.CCR-03-0264","article-title":"A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin \u00df","volume":"10","author":"He","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2011.12.441_bb0225","first-page":"7","article-title":"Human chorionic gonadotropin as a target for cancer vaccines","volume":"6","author":"Triozzi","year":"1999","journal-title":"Oncol Rep"}],"updated-by":[{"DOI":"10.1016\/j.ygyno.2013.02.009","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"record-id":"3447"},{"DOI":"10.1016\/j.ygyno.2013.02.009","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000}}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811014363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811014363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T13:36:26Z","timestamp":1640093786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811014363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0090825811014363"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.12.441","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}